Literature DB >> 1233237

Effect of particle size on the bioavailability of digoxin.

A J Jounela, P J Pentikäinen, A Sothmann.   

Abstract

The bioavailability of digoxin in three tablets prepared from materials with different particle sizes was measured in healthy volunteers in a cross-over study using an alcoholic solution of digoxin as a reference standard. Its bioavailability in tablets with particle sizes of 7 mu or 13 mu was 78-97% of that of digoxin in solution. The tablet with largest particle size (102 mu) showed markedly lower bioavailability than the reference solution, namely 39%. It is obvious that particle size is an important determinant of the dissolution rate and bioavailability of digoxin.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1233237     DOI: 10.1007/bf00562664

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  16 in total

1.  Particle size and absorption of digoxin.

Authors:  T R Shaw; J E Carless; M R Howard; K Raymond
Journal:  Lancet       Date:  1973-07       Impact factor: 79.321

2.  Variation in the biological availability of digoxin.

Authors:  T R Shaw; M R Howard; J Hamer
Journal:  Lancet       Date:  1972-08-12       Impact factor: 79.321

3.  Evaluation of digoxin bioavailability in single-dose studies.

Authors:  D J Greenblatt; D W Duhme; J Koch-Weser; T W Smith
Journal:  N Engl J Med       Date:  1973-09-27       Impact factor: 91.245

4.  Absorption of orally given digoxin preparations.

Authors:  D H Huffman; D L Azarnoff
Journal:  JAMA       Date:  1972-11-20       Impact factor: 56.272

5.  Therapeutic non-equivalence of digoxin tablets in the United Kingdom: correlation with tablet dissolution rate.

Authors:  T R Shaw; K Raymond; M R Howard; J Hamer
Journal:  Br Med J       Date:  1973-12-29

6.  Pharmacokinetics of digoxin: interpreting bioavailability.

Authors:  N Sanchez; L B Sheiner; H Halkin; K L Melmon
Journal:  Br Med J       Date:  1973-10-20

7.  Variation in biologic availability of digoxin from four preparations.

Authors:  J Lindenbaum; M H Mellow; M O Blackstone; V P Butler
Journal:  N Engl J Med       Date:  1971-12-09       Impact factor: 91.245

8.  Determination of therapeutic and toxic serum digoxin concentrations by radioimmunoassay.

Authors:  T W Smith; V P Butler; E Haber
Journal:  N Engl J Med       Date:  1969-11-27       Impact factor: 91.245

9.  The effect of particle size reduction on digoxin crystal properties.

Authors:  A T Florence; E G Salole; J B Stenlake
Journal:  J Pharm Pharmacol       Date:  1974-06       Impact factor: 3.765

10.  Biological availability of digoxin from Lanoxin produced in the United Kingdom.

Authors:  B F Johnson; A S Fowle; S Lader; J Fox; A D Munro-Faure
Journal:  Br Med J       Date:  1973-11-10
View more
  15 in total

1.  Influence of hydrodynamics and particle size on the absorption of felodipine in labradors.

Authors:  Annette Scholz; Bertil Abrahamsson; Steffen M Diebold; Edmund Kostewicz; Britta I Polentarutti; Anna-Lena Ungell; Jennifer B Dressman
Journal:  Pharm Res       Date:  2002-01       Impact factor: 4.200

2.  Evidence for dissolution rate-limited absorption of COL-3, a matrix metalloproteinase inhibitor, leading to the irregular absorption profile in rats after oral administration.

Authors:  Jing Li; Hung Huynh; Eli Chan
Journal:  Pharm Res       Date:  2002-11       Impact factor: 4.200

Review 3.  Pharmacological treatment of cardiac glycoside poisoning.

Authors:  Darren M Roberts; Gamini Gallapatthy; Asunga Dunuwille; Betty S Chan
Journal:  Br J Clin Pharmacol       Date:  2015-12-15       Impact factor: 4.335

4.  [Isomerisation and bioavailability of beta- and alpha-acetyldigoxin (author's transl)].

Authors:  N Rietbrock; H F Vöhringer; J Kuhlmann; K Maertin
Journal:  Klin Wochenschr       Date:  1977-07-01

5.  Guidance in the setting of drug particle size specifications to minimize variability in absorption.

Authors:  K C Johnson; A C Swindell
Journal:  Pharm Res       Date:  1996-12       Impact factor: 4.200

6.  An integrated model for determining causes of poor oral drug absorption.

Authors:  L X Yu
Journal:  Pharm Res       Date:  1999-12       Impact factor: 4.200

7.  A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability.

Authors:  G L Amidon; H Lennernäs; V P Shah; J R Crison
Journal:  Pharm Res       Date:  1995-03       Impact factor: 4.200

8.  The influence of digoxin particle size on absorption of digoxin and the effect of propantheline and metoclopramide.

Authors:  B F Johnson; J O'Grady; C Bye
Journal:  Br J Clin Pharmacol       Date:  1978-05       Impact factor: 4.335

Review 9.  Bioavailability of drugs: the digoxin dilemma.

Authors:  D J Greenblatt; T W Smith; J Koch-Weser
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

Review 10.  Population-based mechanistic prediction of oral drug absorption.

Authors:  Masoud Jamei; David Turner; Jiansong Yang; Sibylle Neuhoff; Sebastian Polak; Amin Rostami-Hodjegan; Geoffrey Tucker
Journal:  AAPS J       Date:  2009-04-21       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.